APA
Ali S. S., Bragin I., Rende E., Mejico L. & Werner K. E. (2019). Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients. : Cureus.
Chicago
Ali Sameer S, Bragin Ilya, Rende Elizabeth, Mejico Luis and Werner Klaus E. 2019. Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients. : Cureus.
Harvard
Ali S. S., Bragin I., Rende E., Mejico L. and Werner K. E. (2019). Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients. : Cureus.
MLA
Ali Sameer S, Bragin Ilya, Rende Elizabeth, Mejico Luis and Werner Klaus E. Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients. : Cureus. 2019.